A Feasibility RCT of Aerobika Verses ACBT in People With COPD

Launched by CARWYN BRIDGES · Sep 16, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods to help people with Chronic Obstructive Pulmonary Disease (COPD) who have trouble clearing mucus from their lungs. The study will compare a special device that helps clear airways with traditional chest physiotherapy exercises. Researchers want to see which method works better for improving symptoms, quality of life, the burden of treatment, and reducing hospital visits over the next year.

To participate, you need to be between 40 and 90 years old, have a diagnosis of COPD, and have been hospitalized recently or treated for a flare-up. You should produce mucus most days, and your doctor must have prescribed the best medications for you. If you're interested, you'll be randomly assigned to one of the two treatments and monitored throughout the year to see how you respond. It's important to know that if you have certain medical conditions, like unstable heart issues or recent bleeding in the lungs, you may not be eligible for this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Admitted to hospital (current inpatient) or recent exacerbation treated in the community within 14 days with systemic steroids and/or antibiotics
• • Male or Female, aged 40-90 years
• • A diagnosis of COPD
• • Greater than 10 pack year history
• • FEV1 /FVC Ratio \<0.70 at any time point in the last 5 years
• • Regular sputum production (most days for at least 3 months)
• • Prescribed optimal pharmacological treatment
• • Able to provide informed consent
• • CAT score \>15
• Exclusion Criteria:
• • Contraindications to OPEP, recent hemoptysis or pneumothorax
• • Unable to use OPEP (manual dexterity)
• • Unstable cardiac conditions in the opinion of the clinical team
• • Life expectancy less than 12 months.